These results highlight for the first time a cascade of events in AML, initiated by the binding of BMP4 to its type 1A receptor that leads to ΔNp73 expression, which in turn induces NANOG by promoter transactivation. The gene discussed is BMP4; the disease is acute myeloid leukemia.